Triple-negative breast cancer (TNBC), the type of the tumor in absence of expression of estrogen receptor (ER), progesterone receptor (PGR) and human epidermal growth factor receptor 2 (HER2) is a common and aggressive subtype of breast cancer with poorer prognosis and shortened survival duration. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.